AzTrials
AzTrials

Regional AnesthesiaNCT06584292

Comparison of Caudal Block and Retrolaminar Block for Circumcision

A study testing caudal block and Retrolaminar block in people with Regional Anesthesia, run by Kanuni Sultan Suleyman Training and Research Hospital at 1 site in Turkey (Türkiye).

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Primary Outcome: Analgesic Efficiency: The primary outcome is the comparison of the analgesic efficacy of the retrolaminar block (RL) versus caudal block (CB) based on postoperative pain scores measured by the FLACC score. This outcome aims to evaluate how effectively each block controls postoperative pain. Read more about this study

Who is it for?
Ages 1 year to 7 years, men only
Conditions the study is for
Regional Anesthesia
What is being tested?
caudal block and Retrolaminar block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteTurkey (Türkiye)
Study dates
27 Sep 2022to 30 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 7 years
  • Men only
  • No healthy volunteers
  • Child

Who may be able to join

  • Pediatric patients aged 1 to 7 years.
  • Classified as American Society of Anesthesiologists (ASA) physical status I-II.
  • Scheduled for elective, unilateral lower abdominal surgery (e.g., orchiopexy or hydrocelectomy) combined with circumcision.
  • Patients whose parents or legal guardians provided written informed consent.

Who cannot join

  • Patients younger than 1 year or older than 7 years.
  • Presence of neurological deficits.
  • Bleeding disorders.
  • History of allergy to local anesthetic drugs.
  • Presence of redness or infection at the injection site on physical examination.
  • Any congenital spinal anomalies.
Show all 9Show fewer
  • Intellectual disabilities or psychiatric disorders.
  • Liver and/or kidney disease.
  • Patients or their guardians who declined to participate in the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Health Science University İstanbul Prof Dr Cemil Taşcıoğlu City Hospital

    Istanbul, Okmeydanı

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Caudal Block and Retrolaminar Block for Postoperative Analgesia in Concurrent Circumcision and Low Abdominal Surgery in Pediatric Patients: A Double-blind, Randomized Controlled Trial

Primary Outcome:

Analgesic Efficiency: The primary outcome is the comparison of the analgesic efficacy of the retrolaminar block (RL) versus caudal block (CB) based on postoperative pain scores measured by the FLACC score. This outcome aims to evaluate how effectively each block controls postoperative pain.

Read more

Secondary Outcomes:

Analgesic Requirements:

The amount of analgesic required within the first 24 hours postoperatively. The time to the first analgesic requirement. These will be recorded during postoperative follow-up visits at 30 minutes, 1, 2, 4, 6, 12, and 24 hours by an anesthesiologist who is blinded to the study groups.

Postoperative Complications:

Urinary Retention: Defined as a distended palpable bladder associated with pain.

Motor Block: The presence of lower extremity motor block will be evaluated using the modified Bromage scale (0: No motor block; 1: Able to move the legs; 2: Unable to move the legs).

Ecchymosis and Hematoma: The presence of ecchymosis (discoloration of the skin due to blood infiltration in the subcutaneous tissues) and hematoma (abnormal swelling or hardening caused by the accumulation of blood) at the injection site will be assessed.

Read the detailed description

This study is a double-blind, randomized controlled trial designed to compare the analgesic efficacy and safety of the retrolaminar block (RL) versus the caudal block (CB) in pediatric patients undergoing concurrent circumcision and lower abdominal surgery. The trial adheres to the ethical principles outlined in the Declaration of Helsinki and was conducted in the Anesthesiology and Reanimation department of a tertiary education and research hospital.

Study Population The study included pediatric patients aged 1 to 7 years who were classified as American Society of Anesthesiologists (ASA) physical status I or II. These patients were scheduled for elective, unilateral lower abdominal surgery (such as orchiopexy or hydrocelectomy) combined with circumcision. The inclusion criteria ensured the selection of otherwise healthy children with no significant comorbidities. Exclusion criteria included patients younger than 1 year or older than 7 years, those with neurological deficits, bleeding disorders, allergy to local anesthetics, infection at the injection site, congenital spinal anomalies, intellectual disabilities, psychiatric disorders, liver and/or kidney diseases, and those who declined to participate.

Randomization and Blinding Participants were randomly assigned to one of two groups (RL block or CB block) using a computer-generated randomization table. The randomization process was designed to ensure an equal distribution of patients across both groups. Both patients and the healthcare professionals involved in postoperative care were blinded to the type of block administered. To maintain blinding, both blocks were performed under sterile conditions, and identical transparent drapes were used to cover the injection sites. An anesthesiologist who was not involved in the block administration was responsible for data collection related to postoperative analgesic requirements and complications.

General Anesthesia Protocol All patients received 0.5 mg/kg of oral midazolam as premedication. In the operating room, standard monitoring was applied, and anesthesia was induced with intravenous (IV) propofol (2 mg/kg) and fentanyl (0.5 µg/kg). After the loss of the eyelash reflex, an appropriately sized laryngeal mask airway (LMA) was placed without the use of neuromuscular blocking agents. Anesthesia was maintained with sevoflurane (2%) in a mixture of 50% oxygen and air. Demographic data, including age, weight, type of surgery, duration of the procedure, and any complications, were recorded.

Regional Anesthesia Procedure Following the induction of general anesthesia and airway management, the patients were placed in the left lateral decubitus position for the regional block procedure. All blocks were performed by a single experienced operator skilled in pediatric ultrasound-guided regional anesthesia, using a 22-G, 50-mm echogenic needle. The ultrasound guidance was provided by a high-frequency (6.5-18 MHz) linear probe.

Caudal Block (CB) Procedure: The sacral hiatus was identified using an out-of-plane transverse ultrasound view at the level of the sacral cornua. The probe was then rotated longitudinally to visualize the sacrococcygeal ligament and sacral bone. A block needle was inserted through the sacrococcygeal membrane into the sacral canal using the in-plane technique, and 0.125% bupivacaine was administered at a dose of 1 mL/kg, with a maximum limit of 20 mL per side.

Retrolaminar Block (RL) Procedure: The RL block was performed with the patient in a lateral decubitus position. The ultrasound probe was positioned at the L4 vertebral level in a paramedian sagittal plane. The probe was moved medially until the vertebral laminae were visualized. The needle was inserted using the in-plane technique, advancing from the cephalad to caudal direction until it contacted the L4 lamina. A dose of 0.1 mL/kg of 0.25% bupivacaine was then injected into the retrolaminar space.

Both blocks were administered bilaterally, and the patients were repositioned supine 15 minutes before the start of the surgery.

Postoperative Monitoring and Follow-up Postoperative monitoring included heart rate, non-invasive blood pressure, and peripheral oxygen saturation. These parameters were recorded before and after the block every 5 minutes. The effectiveness of the block was assessed based on changes in heart rate and blood pressure following the surgical incision. An increase of 20% or more in these values was considered indicative of an unsuccessful block, in which case a rescue dose of fentanyl (0.5 µg/kg IV) was administered.

In the recovery room and at the ward, postoperative pain was evaluated using the FLACC scale at predefined intervals (30 minutes, 1, 2, 4, 6, 12, and 24 hours). The requirement for rescue analgesia was based on the FLACC scores, with IV paracetamol administered for scores of 2 to 4, and IV tramadol for scores above 4. Additionally, postoperative complications such as urinary retention, motor block, and the presence of ecchymosis or hematoma at the injection site were documented by the anesthesiologist blinded to the block type.

Data Collection and Statistical Analysis Demographic characteristics, surgical details, analgesic requirements, and postoperative complications were systematically recorded. The data were analyzed using IBM SPSS Statistics for Windows, Version 22.0. Normality of data distribution was assessed using the Shapiro-Wilk test, and appropriate statistical tests were applied based on data distribution (Student\'s t-test for normally distributed data, Mann-Whitney U test for non-parametric data, and Chi-square or Fisher's exact test for categorical data). Effect sizes were calculated using the Cohen method, and a p-value of less than 0.05 was considered statistically significant.

Randomization and Blinding Randomization was performed using a computer-generated randomization table (http://www. random.org), and patients were divided into two groups: RL and CB. The nurse was blinded to the face, legs, activity, cry, and consolability (FLACC) scores. An anesthesiologist was blinded to data collection regarding analgesic requirement and postoperative complications. Transparent sterile drapes were applied to the injection sites, and both blocks were administered to all patients to evaluate postoperative complications. Thus, the anesthetist was blinded to the postoperative complications.

Being tested
caudal block, Retrolaminar block
Keywords
Caudal block, Retrolaminar block, postoperative pain management

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • caudal blockProcedure or surgery

    Caudal Block (CB) Procedure: The sacral hiatus was identified using an out-of-plane transverse ultrasound view at the level of the sacral cornua. The probe was then rotated longitudinally to visualize the sacrococcygeal ligament and sacral bone. A block needle was inserted through the sacrococcygeal membrane into the sacral canal using the in-plane technique, and 0.125% bupivacaine was administered at a dose of 1 mL/kg, with a maximum limit of 20 mL per side.

  • Retrolaminar blockProcedure or surgery

    Retrolaminar Block (RL) Procedure: The RL block was performed with the patient in a lateral decubitus position. The ultrasound probe was positioned at the L4 vertebral level in a paramedian sagittal plane. The probe was moved medially until the vertebral laminae were visualized. The needle was inserted using the in-plane technique, advancing from the cephalad to caudal direction until it contacted the L4 lamina. A dose of 0.1 mL/kg of 0.25% bupivacaine was then injected into the retrolaminar space.

Study groups in NCT06584292
Study groupRoleWhat they receive
Caudal blockActive comparatorCaudal Block (CB) will applied to the patients.
Receives: Procedure: caudal block
Retrolaminar BlockActive comparatorRetrolaminar Block (RL) will applied to the patients.
Receives: Procedure: Retrolaminar block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analgesic Efficiency

    The primary outcome is the comparison of the analgesic efficacy of the retrolaminar block (RL) versus caudal block (CB) based on postoperative pain scores measured by the Face, Legs, Activity, Cry, Consolability (FLACC) scale. The FLACC scale is used to assess pain in pediatric patients, with scores ranging from 0 to 10. A score of 0 indicates no pain, while a score of 10 represents severe pain. Therefore, higher scores indicate worse pain outcomes. This outcome aims to evaluate how effectively each block controls postoperative pain.

    Measured: 1 day

Secondary outcomes (2)
  1. Analgesic Requirements:

    The amount of analgesic required within the first 24 hours postoperatively. The time to the first analgesic requirement. These will be recorded during postoperative follow-up visits at 30 minutes, 1, 2, 4, 6, 12, and 24 hours by an anesthesiologist who is blinded to the study groups.

    Measured: 1 day

  2. Postoperative Complications:

    Urinary Retention: Defined as a distended palpable bladder associated with pain.

    Motor Block: The presence of lower extremity motor block will be evaluated using the modified Bromage scale (0: No motor block; 1: Able to move the legs; 2: Unable to move the legs).

    Ecchymosis and Hematoma: The presence of ecchymosis (discoloration of the skin due to blood infiltration in the subcutaneous tissues) and hematoma (abnormal swelling or hardening caused by the accumulation of blood) at the injection site will be assessed.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2024
  2. Study start27 Sep 2022
  3. Primary completion15 Dec 2024 (estimated)
  4. Study completion30 Dec 2024 (estimated)

Why it stopped: we couldn't find enough patient.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06584292
Sponsor's protocol ID
retrolaminar blok
Status last verified
Feb 2025
First submitted
2 Sep 2024
Last updated
19 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing caudal block and Retrolaminar block in people with Regional Anesthesia, run by Kanuni Sultan Suleyman Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 19 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analgesic Efficiency (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in